Answer
Thyroid function is monitored regularly during somapacitan treatment because growth hormone increases conversion of T4 to T3 outside the thyroid and may unmask incipient hypothyroidism, which interferes with the response to growth hormone therapy and requires thyroid hormone replacement when indicated.
Sources for this answer
- Sogroya 10mg/1.5 mL solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked